{
  "trial_id": "NCT00406978",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "study",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "legally consenting age",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "willing and able to comply with protocol requirements",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "voluntary written informed consent",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "female patient post-menopausal or surgically sterilized",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "male patient agrees to use contraception",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "previously diagnosed with multiple myeloma",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "relapsed after one line of treatment but less than three lines",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "measurable disease",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Karnofsky performance status \u226560%",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "life-expectancy >3 months",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "laboratory values within 14 days before Baseline",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "study",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "serious medical condition or laboratory abnormality",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "pregnant or breastfeeding females",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "condition that places subject at unacceptable risk",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "use of concomitant anti-myeloma drug or therapy",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "known positive for HIV or active infectious hepatitis",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "other concurrent anticoagulation treatment",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has multiple myeloma with relapse after one line of treatment, measurable disease, and Karnofsky performance status \u226560%. She is on hemodialysis for ESRD. However, she was previously treated with thalidomide velcade and thalidomide which were eventually held due to worsening edema and kidney function.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT00406978",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}